Ultrasound-Targeted Microbubble Destruction-Mediated Downregulation of EZH2 Inhibits Stemness and Epithelial-Mesenchymal Transition of Liver Cancer Stem Cells

References

• Song HJ, Jiang X, Henry L, Nguyen MH, Park H. Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2020;14(10):020–02854.
   Google Scholar
• Lin Z-L, Ding J, Sun G-P, et al. Application of Paclitaxel-loaded EGFR peptide-conjugated magnetic polymeric liposomes for liver cancer therapy. Curr Med Sci. 2020;40(1):145–154. doi:10.1007/s11596-020-2158-4
   PubMed Web of Science ®Google Scholar
• Ruman U, Fakurazi S, Masarudin MJ, Hussein MZ. Nanocarrier-based therapeutics and theranostics drug delivery systems for next generation of liver cancer nanodrug modalities. Int J Nanomedicine. 2020;15:1437–1456. doi:10.2147/IJN.S236927
   PubMed Web of Science ®Google Scholar
• Lo KM, Wu VW, Li Y, Jun XH. Factors affecting target motion in stereotactic body radiotherapy of liver cancer using CyberKnife. J Med Imaging Radiat Oncol. 2020;15(10):1754–9485.
   Google Scholar
• Liu Q, Sun J, Luo Q, Ju Y, Song G. Salinomycin suppresses tumorigenicity of liver cancer stem cells and Wnt/beta-catenin signaling. Curr Stem Cell Res Ther. 2020;23:103860.
   Google Scholar
• Wang LT, Wang SN, Chiou SS, et al. TIP60-dependent acetylation of the SPZ1-TWIST complex promotes epithelial-mesenchymal transition and metastasis in liver cancer. Oncogene. 2019;38(4):518–532. doi:10.1038/s41388-018-0457-z
   PubMed Web of Science ®Google Scholar
• Li N, Zhu Y. Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma. Therap Adv Gastroenterol. 2019;12:1756284818821560. doi:10.1177/1756284818821560
   Web of Science ®Google Scholar
• Ishiguro K, Yan IK, Lewis-Tuffin L, Patel T. Targeting liver cancer stem cells using engineered biological nanoparticles for the treatment of hepatocellular cancer. Hepatol Commun. 2020;4(2):298–313. doi:10.1002/hep4.1462
   PubMed Web of Science ®Google Scholar
• Inamura K, Komizu Y, Yamakuchi M, Ishida S, Matsumoto Y, Matsushita T. Inhibitory effect of hybrid liposomes on the growth of liver cancer stem cells. Biochem Biophys Res Commun. 2019;509(1):268–274. doi:10.1016/j.bbrc.2018.12.118
   PubMed Web of Science ®Google Scholar
• Zhu Y, Tang H, Zhang L, et al. Suppression of miR-21-3p enhances TRAIL-mediated apoptosis in liver cancer stem cells by suppressing the PI3K/Akt/Bad cascade via regulating PTEN. Cancer Manag Res. 2019;11:955–968. doi:10.2147/CMAR.S183328
   PubMed Web of Science ®Google Scholar
• Wang H, Unternaehrer JJ. Epithelial-mesenchymal transition and cancer stem cells: at the crossroads of differentiation and dedifferentiation. Dev Dyn. 2019;248(1):10–20. doi:10.1002/dvdy.24678
   PubMed Web of Science ®Google Scholar
• Tao C, Huang K, Shi J, Hu Q, Li K, Zhu X. Genomics and prognosis analysis of epithelial-mesenchymal transition in glioma. Front Oncol. 2020;10:183. doi:10.3389/fonc.2020.00183
   PubMed Web of Science ®Google Scholar
• Ishiwata T. Cancer stem cells and epithelial-mesenchymal transition: novel therapeutic targets for cancer. Pathol Int. 2016;66(11):601–608. doi:10.1111/pin.12447
   PubMed Web of Science ®Google Scholar
• Jin W. Role of JAK/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial-mesenchymal transition. Cells. 2020;9:1. doi:10.3390/cells9010217
   Web of Science ®Google Scholar
• Yang SW, Zhang ZG, Hao YX, et al. HIF-1alpha induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway. Oncotarget. 2017;8(6):9535–9545. doi:10.18632/oncotarget.14484
   PubMedGoogle Scholar
• Zhang Q, Dong P, Liu X, Sakuragi N, Guo SW. Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis. Sci Rep. 2017;7(1):017–06920.
   PubMedGoogle Scholar
• Gan L, Xu M, Hua R, et al. The polycomb group protein EZH2 induces epithelial-mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter. J Hematol Oncol. 2018;11(1):017–0547. doi:10.1186/s13045-017-0547-3
   PubMedGoogle Scholar
• Ma J, Zhang J, Weng YC, Wang JC. EZH2-mediated microRNA-139-5p regulates epithelial-mesenchymal transition and lymph node metastasis of pancreatic cancer. Mol Cells. 2018;41(9):868–880. doi:10.14348/molcells.2018.0109
   PubMed Web of Science ®Google Scholar
• Xu J, Wang Y, Li Z, Wang Q, Zhou X, Wu W. Ultrasound-Targeted Microbubble Destruction (UTMD) combined with liposome increases the effectiveness of suppressing proliferation, migration, invasion, and Epithelial- Mesenchymal Transition (EMT) via Targeting Metadherin (MTDH) by ShRNA. Med Sci Monit. 2019;25:2640–2648. doi:10.12659/MSM.912955
   PubMed Web of Science ®Google Scholar
• Yang H, Sun Y, Wei J, et al. The effects of ultrasound-targeted microbubble destruction (UTMD) carrying IL-8 monoclonal antibody on the inflammatory responses and stability of atherosclerotic plaques. Biomed Pharmacother. 2019;118(109161):30. doi:10.1016/j.biopha.2019.109161
   Google Scholar
• Huang S, Ren Y, Wang X, et al. Application of ultrasound-targeted microbubble destruction-mediated exogenous gene transfer in treating various renal diseases. Hum Gene Ther. 2019;30(2):127–138. doi:10.1089/hum.2018.070
   PubMed Web of Science ®Google Scholar
• Zhang D, Yang L, Tian H, et al. [Enhancement of gene transfection efficiency and therapeutic effect of ultrasound-targeted microbubble destruction in vivo with cationic microbubble]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018;32(2):228–236. doi:10.7507/1002-1892.201706058.Chinese.
   PubMedGoogle Scholar
• Yu L, Wu X, Chen M, et al. The effects and mechanism of YK-4-279 in combination with docetaxel on prostate cancer. Int J Med Sci. 2017;14(4):356–366. doi:10.7150/ijms.18382
   PubMed Web of Science ®Google Scholar
• Arnold CR, Mangesius J, Skvortsova -I-I, Ganswindt U. The role of cancer stem cells in radiation resistance. Front Oncol. 2020;10:10. doi:10.3389/fonc.2020.00164
   PubMedGoogle Scholar
• Scriba LD, Bornstein SR, Santambrogio A, et al. Cancer stem cells in pheochromocytoma and paraganglioma. Front Endocrinol. 2020;11:79. doi:10.3389/fendo.2020.00079
   PubMed Web of Science ®Google Scholar
• Rozeik MS, Hammam OA, Ali AI, et al. Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma. Electron Physician. 2017;9(7):4708–4717. doi:10.19082/4708
   PubMedGoogle Scholar
• Tang H, Jin Y, Jin S, Tan Z, Peng Z, Kuang Y. Arsenite inhibits the function of CD133(+) CD13(+) liver cancer stem cells by reducing PML and Oct4 protein expression. Tumour Biol. 2016;37(10):14103–14115. doi:10.1007/s13277-016-5195-7
   PubMedGoogle Scholar
• Liu YM, Li XF, Liu H, Wu XL. Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells. Oncol Rep. 2015;34(6):2977–2986. doi:10.3892/or.2015.4270
   PubMed Web of Science ®Google Scholar
• Ma S. Biology and clinical implications of CD133(+) liver cancer stem cells. Exp Cell Res. 2013;319(2):126–132. doi:10.1016/j.yexcr.2012.09.007
   PubMed Web of Science ®Google Scholar
• Huang H, Hu M, Li P, Lu C, Li M. Mir-152 inhibits cell proliferation and colony formation of CD133(+) liver cancer stem cells by targeting KIT. Tumour Biol. 2015;36(2):921–928. doi:10.1007/s13277-014-2719-x
   PubMedGoogle Scholar
• Lu DG, Tang QL, Wei JH, He FY, Lu L, Tang YJ. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition. Eur Rev Med Pharmacol Sci. 2020;24(4):1656–1665. doi:10.26355/eurrev_202002_20339
   PubMed Web of Science ®Google Scholar
• Wang S, Cai L, Zhang F, Shang X, Xiao R, Zhou H. Inhibition of EZH2 attenuates sorafenib resistance by targeting NOTCH1 activation-dependent liver cancer stem cells via NOTCH1-related MicroRNAs in hepatocellular carcinoma. Transl Oncol. 2020;13(3):100741. doi:10.1016/j.tranon.2020.01.002
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66:2–25. doi:10.1016/j.addr.2013.11.009
   PubMed Web of Science ®Google Scholar
• Saw PE, Xu X, Zhang M, Cao S, Farokhzad OC, Wu J. Nanostructure engineering by simple tuning of lipid combinations. Angew Chem Int Ed Engl. 2020;59(15):6249–6252. doi:10.1002/anie.201916574
   PubMed Web of Science ®Google Scholar
• Kumar P, Nagarajan A, Uchil PD. Selective agents for stable transfection. Cold Spring Harb Protoc. 2018;2018:9. doi:10.1101/pdb.top096230
   Google Scholar
• Wu Y, Sun T, Tang J, Liu Y, Li F. Ultrasound-targeted microbubble destruction enhances the antitumor efficacy of doxorubicin in a mouse hepatocellular carcinoma model. Ultrasound Med Biol. 2020;46(3):679–689. doi:10.1016/j.ultrasmedbio.2019.09.017
   PubMed Web of Science ®Google Scholar
• Chen Q, Lin W, Yin Z, et al. Melittin inhibits hypoxia-induced vasculogenic mimicry formation and epithelial-mesenchymal transition through suppression of HIF-1alpha/Akt pathway in liver cancer. Evid Based Complement Alternat Med. 2019;1:9602935.
   Google Scholar
• Ding S-M, Lu A-L, Lu J-F, et al. Macrovascular endothelial cells enhance the motility of liver cancer cells by up-regulation of MMP-3, activation of Integrin/FAK signaling pathway and induction of non-classical epithelial-mesenchymal transition. J Cancer. 2020;11(8):2044–2059. doi:10.7150/jca.38209
   PubMed Web of Science ®Google Scholar
• Chen MJ, Deng J, Chen C, Hu W, Yuan YC, Xia ZK. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis. Int J Biochem Cell Biol. 2019;113:27–36. doi:10.1016/j.biocel.2019.05.011
   PubMed Web of Science ®Google Scholar